Mycophenolate-Induced Posterior Reversible Encephalopathy Syndrome

被引:10
|
作者
Khajuria, Bhavik [1 ]
Khajuria, Mansi [2 ]
Agrawal, Yashwant [3 ]
机构
[1] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Western Michigan Univ, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA
关键词
posterior reversible encephalopathy syndrome; PRES; mycophenolate; mycophenolic acid;
D O I
10.1097/MJT.0000000000000270
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A 29-year-old woman presented with diffuse anasarca and shortness of breath. Workup revealed a creatinine of 3.3 and a glomerular filtration rate of 17. The patient was also found to be pancytopenic with evidence of hemolytic anemia. A renal biopsy showed evidence of stage IV lupus nephritis with rapidly progressive glomerulonephritis. Her lupus was further classified as ANA negative and anti-dsDNA positive. Mycophenolate and triweekly hemodialysis were started along with a steroid burst of methylprednisolone 1 g for 3 days followed by prednisone 60 mg daily. Four days after discharge, the patient represented with a witnessed 3-minute seizure involving bowel incontinence, altered mental status, and tongue biting. She was given 2 mg intravenous lorazepam and loaded with 1000 mg levetiracetam for seizure prophylaxis. Magnetic resonance imaging of the head revealed bilateral posterior hemispheric subcortical edema, and the diagnosis of posterior reversible encephalopathy syndrome was made. Mycophenolate was immediately discontinued and replaced with cyclophosphamide. Strict blood pressure control below 140/ 90 mm Hg was maintained initially with intravenous nicardipine drip and then transitioned to oral nifedipine, clonidine, losartan, and minoxidil. A repeat head magnetic resonance imaging 8 days later showed resolved subcortical edema consistent with the patient's improved mental status. No permanent neurologic sequelae were recorded as a result of this hospital episode.
引用
收藏
页码:E1072 / E1073
页数:2
相关论文
共 50 条
  • [1] Desmopressin-induced Posterior Reversible Encephalopathy Syndrome
    Wei, Ruili
    Jin, Lu
    Huang, Jianhe
    Luo, Benyan
    INTERNAL MEDICINE, 2012, 51 (21) : 3081 - 3084
  • [2] Methotrexate-induced posterior reversible encephalopathy syndrome
    Aradillas, E.
    Arora, R.
    Gasperino, J.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (04) : 529 - 536
  • [3] Vinblastine-induced posterior reversible encephalopathy syndrome
    Ayesh , Mahmoud H.
    Eyadeh, Ahmed
    Rawashdeh, Rand A. L.
    Khasawneh, Ruba
    Saleh, Judy A.
    Jibreel, Malak J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (08) : 2019 - 2022
  • [4] Posterior Reversible Encephalopathy Syndrome
    Sundin, Courtney Stanley
    Johnson, Michelle Laurane
    MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING, 2018, 43 (02) : 77 - 82
  • [5] Posterior reversible encephalopathy syndrome
    Pula, John H.
    Eggenberger, Eric
    CURRENT OPINION IN OPHTHALMOLOGY, 2008, 19 (06) : 479 - 484
  • [6] Posterior reversible encephalopathy syndrome
    Staykov, D.
    Schwab, S.
    NERVENARZT, 2012, 83 (08): : 1013 - +
  • [7] Posterior reversible encephalopathy syndrome
    Staykov, D.
    Schwab, S.
    NERVENARZT, 2012, 83 (08): : 1013 - +
  • [8] Posterior reversible encephalopathy syndrome
    Yasuhara, Takao
    Tokunaga, Koji
    Hishikawa, Tomohito
    Ono, Shigeki
    Miyoshi, Yasuyuki
    Sugiu, Kenji
    Date, Isao
    JOURNAL OF CLINICAL NEUROSCIENCE, 2011, 18 (03) : 406 - 409
  • [9] Posterior reversible encephalopathy syndrome
    Skvortsova, V. I.
    Gubskiy, L. V.
    Melnikova, E. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (05) : 104 - 109
  • [10] PAZOPANIB INDUCED UNILATERAL POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
    Arslan, Muhsine Beyza
    Bajraml, Arsida
    Demir, Elif
    Cabalar, Murat
    Yayla, Vildan
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2017, 70 (3-4): : 140 - 144